NAFDAC Alerts Public on Recall of Deekins Amoxycillin Capsules After Severe Adverse Reactions
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a recall for a specific batch of Deekins Amoxycillin 500mg capsules, following reports of severe adverse drug reactions linked to this batch.
The recalled batch, identified by lot number 4C639001, was produced by Eco-med Pharma Ltd and distributed by DevineKings Pharmaceutical Ltd.
NAFDAC’s recall notice, issued on Wednesday via the agency’s X (formerly Twitter) account, warned both healthcare professionals and consumers to discontinue the use of the affected batch. The recall was prompted after a hospital reported three cases of severe reactions in patients who had been administered capsules from this lot.
Amoxicillin, the active ingredient in the recalled capsules, is a widely used penicillin antibiotic commonly prescribed for bacterial infections, including tonsillitis, bronchitis, sinusitis, pneumonia, and skin infections, urinary tract, ear, nose, and throat infections. Despite its widespread use, the batch in question has been linked to serious health concerns.
NAFDAC is urging the public to remain vigilant and report any cases of suspected substandard or counterfeit medicines to the nearest NAFDAC office. Consumers and healthcare professionals can also reach the agency through its helpline at 0800-162-3322 or by emailing sf.alert@nafdac.gov.ng.
